Page last updated: 2024-09-03

y 27632 and Cancer of Ovary

y 27632 has been researched along with Cancer of Ovary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, YK; Hwang, H; Kim, EK; Park, J; Suh, PG1
Cho, KH; Han, JW; Jeong, KJ; Kang, J; Kim, YK; Lee, HY; Lee, J; Park, CG; Park, SY; Sohn, JS1

Other Studies

2 other study(ies) available for y 27632 and Cancer of Ovary

ArticleYear
RhoA and Rac1 play independent roles in lysophosphatidic acid-induced ovarian cancer chemotaxis.
    Integrative biology : quantitative biosciences from nano to macro, 2014, Volume: 6, Issue:3

    Topics: ADP Ribose Transferases; Amides; Aminoquinolines; Botulinum Toxins; Cell Line, Tumor; Chemotaxis; Enzyme Inhibitors; Female; Guanine Nucleotide Exchange Factors; Humans; Lysophospholipids; Microfluidic Analytical Techniques; Ovarian Neoplasms; Pyridines; Pyrimidines; rac1 GTP-Binding Protein; rho-Associated Kinases; rhoA GTP-Binding Protein

2014
The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
    Oncogene, 2012, Sep-27, Volume: 31, Issue:39

    Topics: Amides; Cell Line, Tumor; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; Neoplasm Invasiveness; NF-kappa B; Nitriles; Ovarian Neoplasms; Peptide Hydrolases; Pyridines; rho-Associated Kinases; Sulfones; Urokinase-Type Plasminogen Activator

2012